Pharma Mar (Spain) Price on September 19, 2024

PHM Stock  EUR 78.10  0.55  0.71%   
If you're considering investing in Pharma Stock, it is important to understand the factors that can impact its price. As of today, the current price of Pharma Mar stands at 78.10, as last reported on the 30th of November, with the highest price reaching 79.00 and the lowest price hitting 77.50 during the day. Pharma Mar is very steady given 3 months investment horizon. Pharma Mar SA maintains Sharpe Ratio (i.e., Efficiency) of 0.23, which implies the firm had a 0.23% return per unit of risk over the last 3 months. We have collected data for thirty different technical indicators, which can help you to evaluate if expected returns of 1.04% are justified by taking the suggested risk. Use Pharma Mar Coefficient Of Variation of 416.89, semi deviation of 1.32, and Risk Adjusted Performance of 0.1917 to evaluate company specific risk that cannot be diversified away.
  
Pharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2329

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPHM
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.48
  actual daily
39
61% of assets are more volatile

Expected Return

 1.04
  actual daily
20
80% of assets have higher returns

Risk-Adjusted Return

 0.23
  actual daily
18
82% of assets perform better
Based on monthly moving average Pharma Mar is performing at about 18% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharma Mar by adding it to a well-diversified portfolio.

Pharma Mar Valuation on September 19, 2024

It is possible to determine the worth of Pharma Mar on a given historical date. On September 19, 2024 Pharma was worth 46.2 at the beginning of the trading date compared to the closed value of 47.52. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pharma Mar stock. Still, in general, we apply an absolute valuation method to find Pharma Mar's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pharma Mar where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pharma Mar's related companies.
 Open High Low Close Volume
  42.58    45.44    42.58    45.26    88,438  
09/19/2024
  46.20    47.94    45.62    47.52    114,571  
  48.34    48.90    47.50    47.62    78,769  
Backtest Pharma Mar  |  Pharma Mar History  |  Pharma Mar Valuation   PreviousNext  
Open Value
46.2
47.52
Closing Value
59.63
Upside

Pharma Mar Trading Date Momentum on September 19, 2024

On September 20 2024 Pharma Mar SA was traded for  47.62  at the closing time. The maximum traded price for the trading interval was 48.90  and the lowest daily price was  47.50 . The daily volume was recorded at 78.8 K. The volume of trading on 20th of September 2024 played a part in the next trading day price growth. The trading delta at closing time to the next closing price was 0.21% . The trading delta at closing time to the closing price today is 4.12% .

Pharma Mar SA Fundamentals Correlations and Trends

By evaluating Pharma Mar's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pharma Mar's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pharma financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Pharma Mar Stock history

Pharma Mar investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pharma Mar SA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pharma Mar stock prices may prove useful in developing a viable investing in Pharma Mar
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain. PHARMA MAR operates under Biotechnology classification in Spain and is traded on Madrid SE C.A.T.S.. It employs 599 people.

Pharma Mar Stock Technical Analysis

Pharma Mar technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Pharma Mar technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Pharma Mar trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Pharma Mar Period Price Range

Low
November 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Pharma Mar SA cannot be verified against its exchange. Please verify the symbol is currently traded on Madrid Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Pharma Mar November 30, 2024 Market Strength

Market strength indicators help investors to evaluate how Pharma Mar stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pharma Mar shares will generate the highest return on investment. By undertsting and applying Pharma Mar stock market strength indicators, traders can identify Pharma Mar SA entry and exit signals to maximize returns

Pharma Mar Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Pharma Mar's price direction in advance. Along with the technical and fundamental analysis of Pharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Pharma Stock analysis

When running Pharma Mar's price analysis, check to measure Pharma Mar's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Mar is operating at the current time. Most of Pharma Mar's value examination focuses on studying past and present price action to predict the probability of Pharma Mar's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Mar's price. Additionally, you may evaluate how the addition of Pharma Mar to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital